GRAPEFRUIT JUICE INGREDIENTS INTERACT WITH DASATINIB THROUGH INHIBITION OF BREAST CANCER RESISTANCE PROTEIN: A NEW TYPE OF BEVERAGE-DRUG INTERACTION.

被引：0
|
作者：
Fleisher, B. [1 ]
Unum, J. [1 ]
Shao, J. [2 ]
An, G. [2 ]
机构：
[1] Univ Florida, Coll Pharm, Orlando, FL USA
[2] Univ Florida, Coll Pharm, Dept Pharmaceut, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-036
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 9 条
  • [1] Ingredients in Fruit Juices Interact with Dasatinib Through Inhibition of BCRP: A New Mechanism of Beverage-Drug Interaction
    Fleisher, Brett
    Unum, Jesse
    Shao, Jie
    An, Guohua
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (01) : 266 - 275
  • [2] ORANGE JUICE AND APPLE JUICE INGREDIENTS INHIBIT DASATINIB EFFLUX VIA P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN: A NEW TYPE OF BEVERAGE-DRUG INTERACTION
    Unum, J. D.
    Fleisher, B.
    Shao, J.
    An, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S30 - S30
  • [3] Drug-drug interaction between apalutamide and atorvastatin through breast cancer resistance protein in an outpatient
    Watanabe, Ayako
    Momo, Kenji
    Tanaka, Katsumi
    Kida, Masaki
    Kuchira, Remi
    Koshizuka, Hiromi
    Nishimura, Kota
    Morita, Masashi
    Yamamoto, Masahiro
    Sasaki, Tadanori
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (08) : 367 - 369
  • [4] Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization
    Kage, K
    Tsukahara, S
    Sugiyama, T
    Asada, S
    Ishikawa, E
    Tsuruo, T
    Sugimoto, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) : 626 - 630
  • [5] ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning
    Jiang, Dejun
    Lei, Tailong
    Wang, Zhe
    Shen, Chao
    Cao, Dongsheng
    Hou, Tingjun
    JOURNAL OF CHEMINFORMATICS, 2020, 12 (01)
  • [6] Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients
    Yamagata, Tetsuo
    Kusuhara, Hiroyuki
    Morishita, Mariko
    Takayama, Kozo
    Benameur, Hassan
    Sugiyama, Yuichi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) : 1142 - 1148
  • [7] ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning
    Dejun Jiang
    Tailong Lei
    Zhe Wang
    Chao Shen
    Dongsheng Cao
    Tingjun Hou
    Journal of Cheminformatics, 12
  • [8] Noni increased the systemic exposure of methotrexate in rats through inhibition on multi-drug resistance protein 2 (MRP 2) and breast cancer resistance protein (BCRP)
    Hsu, Pei-Wen
    Shia, Chi-Sheng
    Wu, Chen-Teng
    Chang, Nai-Wen
    Chao, Pei-Dawn Lee
    Hou, Yu-Chi
    JOURNAL OF FUNCTIONAL FOODS, 2013, 5 (03) : 1414 - 1420
  • [9] Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure
    Elsby, Robert
    Martin, Paul
    Surry, Dominic
    Sharma, Pradeep
    Fenner, Katherine
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (03) : 398 - 408
1